混合内镜黏膜下剥离术与传统内镜黏膜下剥离术在早期胃肿瘤患者中手术时间差异的比较:多中心随机对照试验(Hybrid-G试验)的研究方案
本研究为研究者发起的多中心、前瞻性、随机、开放标签、平行组试验,计划于2020年8月起在日本9家机构开展,纳入82例符合日本胃癌治疗指南宏观诊断为黏膜内(T1a)分化型癌、直径≤20 mm且无溃疡表现的早期胃肿瘤患者,随机分配至传统内镜黏膜下剥离术(C-ESD)组或混合内镜黏膜下剥离术(H-ESD)组,主要结局为ESD手术时间,旨在验证H-ESD是否优于C-ESD。
要点
- 本试验拟比较H-ESD与C-ESD在早期胃肿瘤患者中的手术时间差异。
- 样本量82例基于主要结局计算,把握度80%,显著性水平0.05,考虑10%脱落。
- 主要结局为ESD手术时间,次要结局包括整块切除、完整切除、治愈性、不良事件等。
核心结论
- 本试验将为H-ESD用于早期胃肿瘤患者的获益与风险提供高质量数据,结果可能改善接受ESD的早期胃肿瘤患者结局。
研究设计与样本
- 研究者发起的多中心、前瞻性、随机、开放标签、平行组试验,计划于2020年8月起在日本9家机构开展。
- 计划招募82例早期胃肿瘤患者,随机分配至C-ESD组或H-ESD组。
- 纳入标准为根据现行日本胃癌治疗指南宏观诊断为黏膜内(T1a)分化型癌、直径≤20 mm且无溃疡表现的患者。
主要发现
- 主要结局为ESD手术时间。
- 次要结局包括黏膜切开、黏膜下剥离的时间与速度、整块切除、完整切除、治愈性、ESD相关不良事件、圈套前剥离范围、注射溶液体积、止血次数与时间、切除标本黏膜下层厚度及移交其他操作者。
- 根据既往比较C-ESD与H-ESD手术时间的报告,假设H-ESD可使对数转换后的手术时间降低0.2(-37%)。
- 估计共需82例参与者以达到80%把握度,采用t检验,显著性水平0.05,并考虑10%脱落。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endoscopic submucosal dissection (ESD) is widely accepted as a local treatment for gastrointestinal tract tumors. As a simplified endoscopic procedure, hybrid ESD (H-ESD) has been performed for colorectal neoplasms in recent times. However, whether H-ESD is superior to conventional ESD (C-ESD) for patients with early gastric neoplasms (EGN) remains unclear. In this trial, we will compare the treatment outcomes of H-ESD and C-ESD. We hypothesize that the procedure time for H-ESD is shorter than that for C-ESD. METHODS: This is an investigator-initiated, multi-center, prospective, randomized, open-label, parallel-group trial to be conducted beginning in August 2020 at nine institutions in Japan. We will determine if H-ESD is superior to C-ESD in terms of procedure time in patients with EGN diagnosed as macroscopically intramucosal (T1a) differentiated carcinoma ≤ 20 mm in diameter without ulcerative findings according to current Japanese gastric cancer treatment guidelines. A total of 82 patients will be recruited and randomly assigned to either the C-ESD or the H-ESD group. The primary outcome is ESD procedure time. Secondary outcomes include mucosal incision, time and speed of submucosal dissection, en bloc resection, complete resection, curability, adverse events related to the ESD procedure, extent of dissection before snaring, volume of injection solution, number and time of hemostasis, thickness of the submucosal layer in the resected specimen, and handover to another operator. The stated sample size was determined based on the primary outcome. According to a previous report comparing the procedure times of C-ESD and H-ESD, we hypothesized that H-ESD would provide a 0.2 reduction in logarithmically concerted procedure time (-37%). We estimated that a total of 82 participants were needed to reach a power of 80% for a t-test with a significance level of 0.05 and considering a 10% dropout. DISCUSSION: This trial will provide high-quality data on the benefits and risks of H-ESD for EGN patients. The results of this study could lead to improved outcomes in patients with EGN undergoing ESD. The results will be presented at national and international meetings and published in peer-reviewed journals. TRIAL REGISTRATION: UMIN-CTR UMIN000041244 . Registered on July 29, 2020.
引用
- Esaki M, Ihara E, Fujii H, et al. Comparison of the procedure time differences between hybrid endoscopic submucosal dissection and conventional endoscopic submucosal dissection in patients with early gastric neoplasms: a study protocol for a multi-center randomized controlled trial (Hybrid-G trial). Trials. 2022. PMID: 35189939. doi:10.1186/s13063-022-06099-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。